scholarly journals STUDI KASUS AKTIVITAS MENGGAMBAR DALAM MENGONTROL GEJALA HALUSINASI DI RSJ PROF. DR. SOERODJO MAGELANG

2020 ◽  
Vol 3 (1) ◽  
pp. 112-117
Author(s):  
Novianti Saptarani ◽  
Erna Erawati ◽  
Angga Sugiarto ◽  
S Suyanta

Latar Belakang :halusinasi merupakan salah satu dari gejala gangguan jiwa yaitu dimana klien mengalami perubahan persepsi sensori : merasakan sensori yang tidak nyata berupa suara, penglihatan, pengecapan, perabaan, atau penghiduan. Intervensi pada halusinasi yaitu untuk mengontrol gejala pada halusinasi diantaranya dengan melakukan aktivitas menggambar. Tujuan : tujuan penelitian ini untuk mengetahui asuhan keperawatan jiwa dengan perubahan persepsi sensori : hausinasi pendengran dengan intervensi aktivitas menggambar Metode : penelitian ini menggunakan metode deskritif dengan menggunakan pendekatan proses keperawatan yang dilakukan selama 5 hari pada klien rawat inap di RSJ Prof. dr. Soerojo Magelang, yang telah didiagnosa skizofrenia dengan fokus perubahan persepsi sensori halusinasi. Teknik pengumpulan data dilakukan dengan wawancara, observasi, dokumen,. Instrumen penelitian menggunakan format PSYRAT (Psychotic Symptom Rating Scale) yang terdiri dari 11 pertanyaan dan format asuhan keperawatan jiwa.    Hasil : dari penelitian terdapat penurunan gejala halusinasi setelah dilakukan aktivitas menggambar yang diukur dengan PSYRAT (Psychotic Symptom Rating Scale). Kesimpulan : dalam menerapkan aktivitas gambar efektif untuk mengontrol gejala halusinasi, namun terdapat faktor faktor yang mempengaruhi aktivitas menggambar     

Author(s):  
G. Haddock ◽  
J. McCarron ◽  
N. Tarrier ◽  
E. B. Faragher

2008 ◽  
Vol 52 (9) ◽  
pp. 1448-1451 ◽  
Author(s):  
Pedro Weslley Rosario

The objective of the present study was to evaluate bone and cardiac abnormalities and symptoms and signs of thyroid hormone excess in women with subclinical hyperthyroidism (SCH) aged < 65 years. Forty-eight women with SCH were evaluated. The control group consisted of 48 euthyroid volunteers. The mean symptom rating scale score was significantly higher in patients. Cardiac involvement, both morphological and affecting systolic and diastolic functions, was also observed in patients. Women with SCH showed a significant increase in serum markers of bone formation and resorption. In addition, bone mineral density (BMD) was lower in the femoral neck but not in the lumbar spine in patients before menopause, whereas a lower BMD was observed at both sites in postmenopausal patients. SCH is not completely asymptomatic in women aged < 65 years, and is associated with heart abnormalities and with increased bone turnover and reduced BMD even before menopause.


Author(s):  
A.E. Shklyaev ◽  
◽  
D.D. Kazarin ◽  
Yu.V. Gorbunov ◽  
◽  
...  

The study aimed to determine the predictive capabilities of the Gastrointestinal Symptom Rating Scale (GSRS) for assessing the effectiveness of eradication therapy in Helicobacter pylori (HP) infected patients with type 2 diabetes mellitus. The study involved 60 patients of both sexes with a diagnosis of type 2 diabetes mellitus and chronic HP-associated gastritis, the average age of patients was 61.9 years, average duration of type 2 diabetes was 10.1 years. For statistical analysis of the data, we used the method of constructing ROC curves, which allowed us to identify prognostic factors (in this case, gastroenterological syndromes, such as abdominal pain, refl ux, indigestion, diarrhea and constipation) that influence the effectiveness of eradication therapy in patients with type 2 diabetes. It was found that high values of refl ux and indigestion syndromes scales of the GSRS are associated with the probability of low eradication therapy response in patients with type 2 diabetes, i.e. these syndromes can act as complicating factors for the elimination of Helicobacter pylori. The obtained data suggest the need for screening diagnostics of Helicobacter pylori, clinical manifestations of gastrointestinal pathology and subsequent etiological and pathogenetic treatment.


2021 ◽  
Vol 42 (5) ◽  
pp. 863-871
Author(s):  
Hye-yeon Jang ◽  
Sang-gu Yu ◽  
Do-hyeong Kim ◽  
Young-su Lee

Objective: The purpose of this study was to investigate the effects of Korean medical treatment on a fibromyalgia patient with gastrointestinal symptoms, using herbal medicines selected according to new rather than existing standards.Method: A 52-year-old female patient with fibromyalgia was treated with Odu-tang and acupuncture, cupping, and moxibustion for 22 days. To evaluate the treatment, we used the Numerical Rating Scale (NRS), American College of Rheumatology’s Preliminary Diagnostic Criteria (ACR), and Korean Gastrointestinal Symptom Rating Scale (KGSRS).Result: Following treatment, pantalgia diminished, NRS, and ACR scores improved, and the GSRS score decreased from 29 to 11.Conclusion: This study suggests that Korean medical treatment could effectively reduce pain and improve digestive symptoms in patients with fibromyalgia. It also presents a new method that considers individual characteristics when choosing herbal medicine.


2013 ◽  
Vol 20 (6) ◽  
pp. 530-541 ◽  
Author(s):  
Alexandre J. S. Morin ◽  
Antoine Tran ◽  
Hervé Caci

2014 ◽  
Vol 29 (S3) ◽  
pp. 658-658
Author(s):  
P. Bergmansl ◽  
L. Hargarter ◽  
P. Cherubin ◽  
E. Rancans ◽  
Y. Bez ◽  
...  

ObjectifsÉvaluer la tolérance, la sécurité d’emploi et la réponse à un traitement par le palmitate de palipéridone (PP) administré en doses mensuelles flexibles dans un sous-groupe de patients adultes atteints de schizophrénie, non-aigus mais symptomatiques, après échec d’un traitement par aripiprazole oral.MéthodesÉtude internationale multicentrique, ouverte, prospective de 6 mois.Paramètres d’évaluationChangement du score total de PANSS, de CGI-S et CGI-C, du fonctionnement personnel et social (Personal and Social Performance Scale [PSP]), des symptômes extrapyramidaux (Extrapyramidal Symptom Rating Scale [ESRS]) et événements indésirables (EIs).RésultatsQuarante-six patients (73,9 % d’hommes, âge moyen 34,4 ± 9,4 ans, 78,3 % souffrant de schizophrénie paranoïde) ont été étudiés. La principale raison de la substitution d’aripiprazole oral (dose moyenne de 22,7 ± 10,7 mg/jour) par le PP était « le choix du patient » (39,1 %) ; 67,4 % des patients ont terminé l’étude à 6 mois. Le score total moyen de PANSS a diminué de 74,7 ± 14,9 à l’inclusion à 62,6 ± 16,5 lors de la dernière observation (soit une variation moyenne de −12,2 ± 16,7 points ; IC 95 % [−17,1 ; −7,2] ; p < 0,0001). Chez 52,2 % des patients, l’amélioration du score total de PANSS a été ≥ 20 % ; le pourcentage de patients considérés légèrement malades ou moins selon les critères de la CGI-S est passé de 23,9 % à 56,5 %. Au total, 75,5 % des patients ont été jugés améliorés à la CGI-C par rapport au traitement antérieur par aripiprazole. Le score de l’échelle de fonctionnement PSP s’est amélioré de 58,9 ± 13,4 à 62,9 ± 15,2 (p = 0,041). Les EIs touchant ≥ 5 % des patients étaient : anxiété (n = 6), douleur au site d’injection, bronchite, insomnie, akathisie (n = 4 chacun) et augmentation du poids, dépression et douleur aux extrémités (n = 3 chacun). Les symptômes extrapyramidaux selon ESRS se sont améliorés de façon significative depuis l’inclusion jusqu’à 6 mois chez les patients ayant terminé l’étude (−1,4 ± 2,7 ; p < 0,006).ConclusionsL’utilisation de doses flexibles de PP a permis une amélioration symptomatologique et fonctionnelle cliniquement significative chez des patients atteints de schizophrénie, non-aigus et en échec de traitement par aripiprazole oral. Le PP a été bien toléré avec une diminution des symptômes extrapyramidaux.


1991 ◽  
Vol 6 (6) ◽  
pp. 301-306 ◽  
Author(s):  
P Bech

SummaryThe algorithms for the demonstration of shared phenomenology of psychiatric syndromes in DSM-III are resistant to quantification. In contrast, the rating scale approach quantifies clinical target syndromes in psychiatry. The two most useful statistical models for quantifying shared phenomenology by symptom rating scales have been reviewed; namely factor analysis and latent structure analysis. Results have shown that factor analysis has demonstrated dimensions of dementia, delirium, schizophrenia, mania, outward aggression, depression and anxiety. Latent structure analysis has confirmed that the items of brief rating scales (such as the Melancholia Scale) are additively related implying that their total scores are sufficient statistics for the measurement of these factors or dimensions. Latent structure analysis should be considered as a psychometric “glasnost” compared to algorithm-resistant logic of quantification in DSM-III.


Sign in / Sign up

Export Citation Format

Share Document